Literature DB >> 12608662

Cellular composition of subacute thyroiditis. an immunohistochemical study of six cases.

Masaru Kojima1, Shigeo Nakamura, Tetsunari Oyama, Shiro Sugihara, Noriyuki Sakata, Nobuhide Masawa.   

Abstract

To clarify the cellular composition of subacute thyroiditis, histologic and immunohistochemical studies were performed. Histologically, the lesion presented a patchy distribution of non-caseous granulomas comprising colloid, small lymphocytes, neutrophils, macrophages with or without epithelioid features, and multinucleated giant cells of foreign body type. In addition, numerous plasmacytoid monocytes were closely associated with the granulomas. The giant cells were CD68+, thyroglobulin- and cytokeratin-. Usually, small lymphocytes in the granulomas are CD3+, CD8+, CD45RO+ cytotoxic T-cells. In the non-granulomatous lesion, the follicles were often infiltrated by CD8+ T-lymphocytes, plasmacytoid monocytes and histiocytes, resulting in disrupted basement membrane and rupture of the follicles. Lymphoid follicles with or without active germinal centers were not observed. Moreover, no residual follicular dendritic cell networks were detected by CD23 and CAN.42 immunostains. In the interfollicular area, scattered plasma cells were observed among infiltrating cells. Neither human herpes virus 8 nor EBER-positive cells were detected in the six patients. The findings of our study suggest that cellular immune response may play an important role in the pathogenesis of subacute thyroiditis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12608662     DOI: 10.1078/0344-0338-00344

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

1.  De Quervain thyroiditis in the course of H1N1 influenza infection.

Authors:  G Michas; G Alevetsovitis; I Andrikou; S Tsimiklis; E Vryonis
Journal:  Hippokratia       Date:  2014-01       Impact factor: 0.471

2.  de Quervain thyroiditis in a young boy following hand-foot-mouth disease.

Authors:  Pontipa Engkakul; Pat Mahachoklertwattana; Preamrudee Poomthavorn
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

Review 3.  Eponym : de Quervain thyroiditis.

Authors:  Pontipa Engkakul; Pat Mahachoklertwattana; Preamrudee Poomthavorn
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

4.  Cellular immunity in subacute thyroiditis: a new perspective through neopterin.

Authors:  Melisa Sahin Tekin; Evin Kocaturk; Sinem Gurcu; Huseyin Kayadibi; Bilge Dibeklioglu; Goknur Yorulmaz
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

5.  Not Just "COVID Anxiety": A Case of Subacute Thyroiditis in a Patient Recovering From SARS-CoV-2 Infection.

Authors:  Hameed Ullah; Ijaz Ali; Fazal Alam; Wajid Ali; Masroor Anwar
Journal:  Cureus       Date:  2022-04-18

6.  Case report: Paradoxical manifestation of covid 19 induced thyroiditis in the unvaccinated patient.

Authors:  Prakash Poudel Jaishi; Sandhya Kiran Neupane; Prabhat Kiran Neupane; Divya Koirala; Arjun Kandel; Kushum Joshi
Journal:  Ann Med Surg (Lond)       Date:  2022-07-20

7.  de Quervain's thyroiditis: A review of experience with surgery.

Authors:  Rohit Ranganath; Manish A Shaha; Bin Xu; Jocelyn Migliacci; Ronald Ghossein; Ashok R Shaha
Journal:  Am J Otolaryngol       Date:  2016-08-18       Impact factor: 1.808

8.  [Clinical practice guidelines for acute and chronic thyroiditis (excluding autoimmune thyroiditis)].

Authors:  E A Troshina; E A Panfilova; M S Mikhina; I V Kim; E S Senyushkina; A A Glibka; B M Shifman; A A Larina; M S Sheremeta; M V Degtyarev; P O Rumyanstsev; N S Kuznetzov; G A Melnichenko; I I Dedov
Journal:  Probl Endokrinol (Mosk)       Date:  2021-04-12

9.  Subacute (De Quervain) thyroiditis during the COVID-19 pandemic.

Authors:  Rodrigo Abreu; Renata Miguel; Mauro Saieg
Journal:  Cancer Cytopathol       Date:  2021-05-10       Impact factor: 4.264

Review 10.  Viruses and thyroiditis: an update.

Authors:  Rachel Desailloud; Didier Hober
Journal:  Virol J       Date:  2009-01-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.